schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
.
.
earn profits from premium commercial properties in india.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.